These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3306001)

  • 41. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
    Forman SJ; Blume KG; Krance RA; Miner PJ; Metter GE; Hill LR; O'Donnell MR; Nademanee AP; Snyder DS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2605-7. PubMed ID: 3079090
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
    Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A
    Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659
    [No Abstract]   [Full Text] [Related]  

  • 44. Bone marrow transplantation.
    Epstein RB; Slease RB
    Surg Annu; 1985; 17():23-39. PubMed ID: 3883542
    [No Abstract]   [Full Text] [Related]  

  • 45. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
    Flowers ME; Martin PJ
    Leuk Lymphoma; 2003 Jul; 44(7):1141-6. PubMed ID: 12916865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Future directions of bone marrow transplantation.
    Buskard NA
    CMAJ; 1987 Aug; 137(4):277-9. PubMed ID: 3300925
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathophysiology and prevention of graft-versus-host disease.
    Storb R
    Prog Clin Biol Res; 1984; 149():337-66. PubMed ID: 6377326
    [No Abstract]   [Full Text] [Related]  

  • 49. Approaches to leukemic relapse following bone marrow transplantation.
    Gale RP
    Transplant Proc; 1978 Mar; 10(1):167-71. PubMed ID: 345557
    [No Abstract]   [Full Text] [Related]  

  • 50. [Bone marrow transplantation in the treatment of acute childhood leukosis].
    Muñoz Villa A; Madero López L
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():52-5. PubMed ID: 6362507
    [No Abstract]   [Full Text] [Related]  

  • 51. Modified methotrexate regimen for prevention of graft-versus-host disease.
    Vowels M; Lam-Po-Tang R; Mameghan H; Ford D; Hughes DO
    Transplant Proc; 1986 Apr; 18(2):276-7. PubMed ID: 3515665
    [No Abstract]   [Full Text] [Related]  

  • 52. Bone marrow transplantation.
    Beard ME
    N Z Med J; 1987 Aug; 100(829):486-8. PubMed ID: 3332040
    [No Abstract]   [Full Text] [Related]  

  • 53. T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
    Champlin R
    J Hematother; 1993; 2(1):27-42. PubMed ID: 7921964
    [No Abstract]   [Full Text] [Related]  

  • 54. Thalidomide responsive chronic pulmonary GVHD.
    Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GA
    Bone Marrow Transplant; 1996 Feb; 17(2):291-3. PubMed ID: 8640183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of monoclonal antibodies to bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1693-701. PubMed ID: 3285796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
    Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.
    Mehta J; Singhal S; Gee AP; Chiang KY; Godder K; Rhee Fv Fv; DeRienzo S; O'Neal W; Lamb L; Henslee-Downey PJ
    Bone Marrow Transplant; 2004 Feb; 33(4):389-96. PubMed ID: 14716338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow harvesting for malignant disease.
    Maitland JA; Treleaven JG; Clink HM
    Eur J Surg Oncol; 1986 Mar; 12(1):5-8. PubMed ID: 3514274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.